• SENSEX 81,411.35
    -499.66 (--0.61%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
Back

Corporate News

Venmax Drugs to review quarterly results at board meeting on November 12, 2026
05-Nov-2026, 05:10

Venmax Drugs and Pharmaceuticals Limited will hold a board meeting on November 12, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026, according to a regulatory filing. The trading window for the company's securities will remain closed for designated persons from October 1, 2026, until November 14, 2026.